Skip to the content
Browse the library

Buchwald–Hartwig amination: 3,5-Dibromopyridine → 1-(5-Bromopyridin-3-yl)-4-methylpiperazine

21% yield, run at 140 °C, as recorded by experimental reaction archive. The written procedure is below.

verified record, 21% yield recorded, Not balanced as written, From experimental reaction archive

Reagents, catalysts and solvents are in the table below.

The atoms, from reactants to products

CNCCNCCNCCBrCCCBr
Reactants · 1/6
breakingformingbond order changesmapped atom that changes

Drawn from the record's atom map: which bonds break and which form between the reactants and products the source listed. It shows a change in connectivity, not a simulated trajectory and not a mechanism.

What was in the flask

RoleSpeciesFormulaYield
Reactant3,5-DibromopyridineC₅H₃Br₂N—
Reactant1-MethylpiperazineC₅H₁₂N₂—
Reagentsodium 2-methylpropan-2-olateC₄H₉NaO—
Catalyst1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)C₃₉H₃₂OP₂—
CatalystBis(dibenzylideneacetone)palladiumC₅₁H₄₂O₃Pd₂—
SolventTolueneC₇H₈—
Product1-(5-Bromopyridin-3-yl)-4-methylpiperazineC₁₀H₁₄BrN₃21.27%

The equation does not balance as written. That is usual for an experimental record: the source listed what it put in and what it measured, not a stoichiometric equation.

Conditions

Temperature
140 °C

Only the dimensions the source stated are listed. Anything absent here was not recorded, and it is not inferred from what the class usually needs.

Yield

  • 21% of 1-(5-Bromopyridin-3-yl)-4-methylpiperazine.

Procedure

Copied from the source record, unedited

Trial # 3: 3,5-dibromopyridine (1000 mg, 4.22 mmol), 1-methylpiperazine (423 mg, 4.22 mmol), Pd2(dba)3 (387 mg, 0.42 mmol), XANTPHOS (366 mg, 0.63 mmol), SODIUM TERT-BUTOXIDE (609 mg, 6.33 mmol), PhCH3 (10 mL) as added to a 10 mL microwave vial. This was degassed and refilled with N2 and then heated at 140 °C in microwave for 1h. LCMS showed reaction done with the peak at Rf0.52 showed a fragment mass of 256. Evaporated solvent. Residue purified by (CH3CN/H2O 0-30%+TFA buffer )to get the desired product 1-(5-bromopyridin-3-yl)-4-methylpiperazine (107 mg, 9.90 %). Trial # 1 3,5-dibromopyridine (1000 mg, 4.22 mmol), 1-methylpiperazine (423 mg, 4.22 mmol), Pd2(dba)3 (387 mg, 0.42 mmol), XANTPHOS (366 mg, 0.63 mmol), [Reactants], PhCH3 (5 mL) as added to a 10 mL microwave vial. This was

The source

This record comes from experimental reaction archive (ord-1cf3f1a64d944eabb1ba184483ae76fd). Open the source and check it against what is on this page.

  • experimental reaction archive record ord-1cf3f1a64d944eabb1ba184483ae76fd from dataset "750 AstraZeneca ELN dataset" (url: https://chemrxiv.org/engage/chemrxiv/article-details/60c9e3f37792a23bfdb2d471). No atom mapping is provided by the source.

    experimental record · quality medium · source

experimental reaction record.

How to read this record

This is one experiment, not a rule. It says that on one occasion these species were combined under these conditions and this came out. It does not say the reaction will give the same result on your substrate, and nothing on the page has been generalised into a claim that it would.

The pathway is a separate question, kept on separate pages. A mechanism here is the canonical arrow pushing for a class, run on real structures and labelled rule-derived. It is not evidence, and this record is not a mechanism.